These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Higher dosing of temozolomide? Regression of an anaplastic oligoastrocytoma over more than three years. Koch D, Wick W. J Neurooncol; 2006 Apr; 77(2):219-20. PubMed ID: 16292485 [No Abstract] [Full Text] [Related]
5. Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Rosenthal MA, Ashley DL, Cher L. Intern Med J; 2002 Jul; 32(7):346-8. PubMed ID: 12088355 [Abstract] [Full Text] [Related]
10. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas? Khasraw M, Bell D, Wheeler H. J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779 [Abstract] [Full Text] [Related]
13. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme. Tan CW, See SJ, Tham CK, Ang AL. Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145 [No Abstract] [Full Text] [Related]
14. Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide. Gorospe Sarasúa L, Ureña-Vacas A, Muñoz Del Toro JR. Arch Bronconeumol; 2016 Oct; 52(10):534-5. PubMed ID: 27021139 [No Abstract] [Full Text] [Related]